Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 3 boards, counting each seat separately. Longest: Supernus Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Alpha Cognition Inc. June 16, 202695.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 16, 2026 | Alpha Cognition Inc. | Grant or award | +5,489 | — | — |
| Feb 19, 2026 | Supernus Pharmaceuticals Inc. | Option exercise | +4,475 | — | — |
| Feb 19, 2026 | Supernus Pharmaceuticals Inc. | Open-market sale | −1,217 | $50.31 | $61,227 |
| Feb 19, 2026 | Supernus Pharmaceuticals Inc. | Open-market sale | −3,258 | $51.27 | $167,038 |
| Aug 14, 2025 | Supernus Pharmaceuticals Inc. | Open-market sale | −5,369 | $42.25 | $226,840 |
| Feb 22, 2025 | Supernus Pharmaceuticals Inc. | Grant or award | +5,369 | — | — |
Questions about Bethany Sensenig
What boards is Bethany Sensenig on?
Bethany Sensenig sits on the boards of Alpha Cognition Inc., Indivior Pharmaceuticals Inc. and Supernus Pharmaceuticals Inc.
How long has Bethany Sensenig served on boards?
Our records show at least 4 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.